Efficacy and Safety of Empagliflozin in NODAT

Clinical trial NCT03642184 · TERMINATED

Trial details

NCT number: NCT03642184
Sponsor: RenJi Hospital
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

New Onset Diabetes After Transplant Kidney Transplant; Complications

Start date: 2018-07-14
Primary completion: 2019-01-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.